Evaluation of Chinese traditional patent medicines against influenza virus in vitro

Yaoxue Xuebao

Volumn 45, Issue 3, 2010, Pages 408-412

  Zu, Mian ^a   Zhou, Dan ^a   Gao, Li ^a   Liu, Ai Lin ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Chinese traditional patent medicine; Cytopathic effect; Influenza virus; Neuraminidase

Indexed keywords

BANLANGEN; CHAIHUANG; CHINESE DRUG; CHUANXINLIAN; FENRE GANMAO; FUFANG JINYINHUA; FUFANG YUXINGCAO; GANMAO QINGRE; JINGAN; JINGZHI YINQIAO; JINMU GANMAO; KANGBINGDU; LANQIN; PUGONGYING; QINGKAILING; QINGRE JIEDU; QINLIAN; REDUNING; SHUANGHUANGLIAN; SIALIDASE; UNCLASSIFIED DRUG; XIAOYAN; XIASANGJU; XINFUFANG DAQINGYE; YINHUANG; YINQIAO JIEDU; ZHIZI JINHUA;

ANTIVIRAL ACTIVITY; ARTICLE; CHINESE MEDICINE; CYTOPATHOGENIC EFFECT; ENZYME INHIBITION; FLUOROMETRY; INFLUENZA; INFLUENZA VIRUS; TABLET;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; MEDICINE, CHINESE TRADITIONAL; NEURAMINIDASE; PLANTS, MEDICINAL;

EID: 77952185879     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Daum LT, Canas LC, Schadler CA, et al. A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses [J]. J Clin Virol, 2002, 25: 345-350.
2. WHO. 2003. Influenza: Overview, http://www.who.int/mediacentre/ factsheets/fs211/en/; March 2003.
3. Liu AL, Du GH. Rational drug screening on neuraminidase inhibitors of influenza virus [J]. Comput Appl Chem, 2004, 21: 178-180.
4. Pinto LH, Lamb RA. Understanding the mechanism of the anti-influenza virus drug amantadine [J]. Trends Microbiol, 1995, 3: 271.
5. Wharton SA, Belshe RB, Skehel JJ, et al. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine [J]. Gen Virol, 1994, 75: 945-948.
6. Hoffmann HH, Palese P, Shaw ML. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity [J]. Antiviral Res, 2008, 80: 124-134.
7. Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States [J]. JAMA, 2006, 295: 891-894.
8. Cheung CL, Rayner JM, Smith GJ, et al. Distribution of amantadine resistant H5N1 avian influenza variants in Asia [J]. J Infect Dis, 2006, 193: 1626-1629.
9. Hung HC, Tseng CP, Yang JM, et al. Aurintricarboxylic acid inhibits influenza virus neuraminidase [J]. Antiviral Res, 2009, 81: 123-131.
10. Liu AL, Wang HD, Yang F, et al. Research progress of neuraminidase inhibitors for anti-influenza [J]. Acta Pharm Sin, 2009, 44: 935-942.
11. Gao L, Chen HS. Inhibiting effect of baicalin on influenza, herpes simplex and CoxB3 virus infections in cultured cells [J]. Chin J New Drugs, 2008, 17: 474-477.
12. Li G, Peng SZ, Yuan SH, et al. Experimental study of anti-influenza virus H5N1 effects of Zhongsheng pill in vivo [J]. World Sci Technol Mod Tradit Chin Med, 2009, 11: 365-370.